Verrica Pharmaceuticals Inc (NASDAQ:VRCA) shares, rose in value on Friday, June 20, with the stock price up by 1.04% to the previous day’s close as strong demand from buyers drove the stock to $0.58.
Actively observing the price movement in the last trading, the stock closed the session at $0.58, falling within a range of $0.5675 and $0.63. The value of beta (5-year monthly) was 1.758. Referring to stock’s 52-week performance, its high was $8.98, and the low was $0.38. On the whole, VRCA has fluctuated by -9.07% over the past month.
With the market capitalization of Verrica Pharmaceuticals Inc currently standing at about $54.08 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-13.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that VRCA’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of VRCA currently trading nearly -1.24% and 8.69% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 49.83, while the 7-day volatility ratio is showing 6.72% which for the 30-day chart, stands at 6.07%. Furthermore, Verrica Pharmaceuticals Inc (VRCA)’s beta value is 1.76, and its average true range (ATR) is 0.07.
A comparison of Verrica Pharmaceuticals Inc (VRCA) with its peers suggests the former has fared considerably weaker in the market. VRCA showed an intraday change of 1.04% in last session, and over the past year, it shrunk by -92.83%%.
Data on historical trading for Verrica Pharmaceuticals Inc (NASDAQ:VRCA) indicates that the trading volumes over the past 10 days have averaged 0.28 and over the past 3 months, they’ve averaged 363.64K. According to company’s latest data on outstanding shares, there are 91.79 million shares outstanding.
Nearly 45.85% of Verrica Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 31.92% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 2.27 million shares as on 2025-05-30, resulting in a short ratio of 9.02. According to the data, the short interest in Verrica Pharmaceuticals Inc (VRCA) stood at 441.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 2.71 million. The stock has fallen by -16.46% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the VRCA stock heading into the next quarter.
